ID: MRFR/MED/0998-CR | 104 Pages | Author: Rahul Gotadki | February 2021
1 Market Overview
1.1 Product Overview And Scope Of Facial Injectable 12
1.2 Specifications Of Facial Injectable 13
1.2.1 Hyaluronic Acid 13
1.2.2 Collagen 13
1.2.3 Botulinum Toxin 13
1.2.4 Polymers And Particles 14
2 Research Methodolgy
2.1 Primary Research: 18
2.2 Secondary Research: 18
3 Market Dynamics
3.1 Drivers 19
3.1.1 Growing Demand For Facial Aesthetic Treatments 19
3.1.2 Technological Advancements 19
3.1.3 Effects Of Pollution 19
3.1.4 Increasing Acceptance Of Soft Tissue Fillers 20
3.1.5 Growing Demand For Dermal Filler Techniques From Asia-Pacific-Pacific 20
3.2 Restraints: 20
3.2.1 Complication During Surgery 20
3.2.2 Side Effects Associated With Facial Injectable 21
3.3 Opportunity 21
3.3.1 Rising Awareness About Combination Therapies 21
3.4 Porters Five Forces 22
3.5 Bargaining Power Of Suppliers 23
3.6 Bargaining Power Of Buyers 23
3.7 Threat Of New Entrants 23
3.8 Threat Of Substitutes 23
3.9 Intensity Of Rivalry 23
3.10 Value Chain Analysis 24
3.10.1 Inputs 24
3.10.2 Drug Development 24
3.10.3 Manufacturing Process Of Facial Injectable 24
3.10.4 Marketing And Distribution 25
3.11 Supply Chain 25
4 Global Facial Injectable Market, By Regions
4.1 Global Facial Injectable Market 27
4.2 North America Facial Injectable Market 29
4.3 North America Facial Injectable Market, By Type 32
4.4 North America Facial Injectable Market, By Application 35
4.5 North America Facial Injectable Market, By End User 35
4.5 North America Facial Injectable Market, By Country: Price (USD) 36
4.5.1 Botulinum Toxin Price: By Country (USD) 36
4.5.2 Hyaluronic Acid Price: By Country (USD) 36
4.5.3 Polymers And Particles Price: By Country (USD) 37
4.5.4 Collagen Price: By Country (USD) 37
4.6 North America Nuber Of Facial Injectable Procedures By Country, 2020–2027 38
4.6.1 Botulinum Toxin 38
4.6.2 Hyaluronic Acid 38
4.6.3 Polymers & Particles 38
4.6.4 Collagen 39
4.7 Us Facial Injectable Market 40
4.7.1 US Facial Injectable Market, By Type 40
4.7.2 US Facial Injectable Market, By Application (USD Million) 41
4.7.3 US Facial Injectable Market, By Type: Price (USD) 42
4 .7.3 US Facial Injectable Market, By End User: Price (USD) 42
4.8 Canada Facial Injectable Market 42
4.8.1 Canada Facial Injectable Market, By Type 42
4.8.2 Canada Facial Injectable Market, By Application 44
4.8.3 Canada Facial Injectable Market, By Type: Price (USD) 45
4.8.3 Canada Facial Injectable Market, By End User: Price (USD) 45
4.9 Europe Facial Injectable Market 45
4.9.1 Europe Facial Injectable Market, By Type 45
4.9.2 Europe Facial Injectable Market, By Application 48
4.9.3 Europe Facial Injectable Market, By Type: Price (USD) 50
4.9.3 Europe Facial Injectable Market, By End User: Price (USD) 50
4.10 Europe Facial Injectable Market, By Country (USD Million) 50
4.10.1 Russia Facial Injectable Market 50
4.10.2 Germany Facial Injectable Market 51
4.10.3 France Facial Injectable Market 51
4.10.4 UK Facial Injectable Market 52
4.10.5 Italy Facial Injectable Market 52
4.10.6 Spain Facial Injectable Market 53
4.10.7 Rest Of Europe Facial Injectable Market 53
4.11 Europe Facial Injectable Market By Type, By Country (Volume) 54
4.11.1 Europe Hyaluronic Acid 54
4.11.2 Europe Botulinum Toxin 54
4.12 Europe Facial Injectable Market, By Application (USD Million) 55
4.12.1 Russia Facial Injectable Market 55
4.12.2 Germany Facial Injectable Market 55
4.12.3 France Facial Injectable Market 55
4.12.4 UK Facial Injectable Market 56
4.12.5 Italy Facial Injectable Market 56
4.12.6 Spain Facial Injectable Market 56
4.12.7 Rest Of Europe Facial Injectable Market 57
4.13 Asia-Pacific Facial Injectable Market 57
4.14 Asia-Pacific Facial Injectable Market, By Type 60
4.14.1 Asia-Pacific Botulinum Toxin Market, By Country 60
4.14.2 Asia-Pacific Hyaluronic Acid Market, By Country 61
4.14.3 Asia-Pacific Polymers & Particles Market, By Country 62
4.14.4 Asia-Pacific Collagen Market, By Country 63
4.15 Asia-Pacific Facial Injectable Market, By Application 63
4.16 Asia-Pacific Facial Injectable Market,By Type: Price (USD) 65
4.17 Asia-Pacific Facial Injectable Procedure: By Country 66
4.17.1 South Korea Facial Injectable Market 68
4.17.2 Japan Facial Injectable Market 69
4.17.3 China Facial Injectable Market 71
4.17.4 India Facial Injectable Market 72
4.17.5 Rest Of Asia-Pacific Facial Injectable Market 73
5 Competitive Landscape
5.1 Global Facial Injectable Market Competition By Manufacturers 75
5.1.1 Global Facial Injectable Sales And Market Share Of
Key Manufacturers (2020 And 2027) 75
5.2 Global Facial Injectable Market: Company Share Analysis, 2020 (%) 76
6 Global Facial Injectable Market: Company Profile
6.1 Galderma 77
6.1.1 Company Overview 78
6.1.2 Product Overview 78
6.1.3 Financial Overview 78
6.1.4 Manufacturing Units. 79
6.2 Allergan 81
6.2.1 Company Overview 81
6.2.2 Product Overview 82
6.2.3 Key Developments 83
6.3 Merz Pharma 84
6.3.1 Company Overview 85
6.3.2 Product Overview 85
6.3.3 Financial Overview 86
6.3.4 Key Devlopments 87
6.3.5 Manufacturing Units 87
6.4 Valeant Pharmaceuticals 88
6.4.1 Company Overview 89
6.4.2 Product Overview 89
6.4.3 Financial Overview 90
6.4.4 Key Developments 90
6.4.5 Manufacturing Units 91
6.5 Integra Lifesciences 94
6.5.1 Company Overview 94
6.5.2 Product Overview 94
6.5.3 Key Developments 95
6.5.4 Manufacturing Units 96
6.6 Sanofi 97
6.6.1 Company Overview 97
6.6.2 Product Overview 97
6.6.3 Financial Overview 98
6.6.4 Key Developments 98
6.7 Sinclair 99
6.7.1 Company Overview 99
6.7.2 Product Overview 99
6.7.3 Financial Overview: 100
6.7.4 Key Developments 100
6.8 Suneva Medical 101
6.8.1 Company Overview 101
6.8.2 Product Overview 101
6.8.3 Financial Overview 101
6.9 Scivision Biotech Inc. 102
6.9.1 Company Overview 102
6.9.2 Product Overview 102
6.9.3 Financial Overview 102
7 Facial Injectable Market: Technology And Development Trend
8 Conclusion
9 List Of Tables
TABLE 1 APPLICATIONS OF FACIAL INJECTABLE 12
TABLE 2 GLOBAL FACIAL INJECTABLE MARKET: MARKET STRUCTURE 16
TABLE 4 GLOBAL FACIAL INJECTABLE MARKET SHARE, BY REGION 2020 (%) 27
TABLE 5 GLOBAL FACIAL INJECTABLE MARKET SHARE, 2020–2027 (%) 28
TABLE 6 GLOBAL FACIAL INJECTABLE MARKET: IMPORT EXPORT DATA 2020 (TONS) 28
TABLE 7 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 29
TABLE 8 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (VOLUME) 30
TABLE 9 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 30
TABLE 10 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 31
TABLE 11 NORTH AMERICA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 31
TABLE 12 NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY (USD MILLION) 32
TABLE 13 NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 33
TABLE 14 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY (USD MILLION) 33
TABLE 15 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 33
TABLE 16 NORTH AMERICA POLYMERS & PARTICLES MARKET, BY COUNTRY (USD MILLION) 33
TABLE 17 NORTH AMERICA CALCIUM HYDROXYLAPATITE MARKET, BY COUNTRY (VOLUME) 34
TABLE 18 NORTH AMERICA POLY-L-LACTIC ACID MARKET, BY COUNTRY (VOLUME) 34
TABLE 19 NORTH AMERICA POLYMETHYLMETHACRYLATE MARKET, BY COUNTRY (VOLUME) 34
TABLE 20 NORTH AMERICA COLLAGEN MARKET, BY COUNTRY (USD MILLION) 34
TABLE 21 NORTH AMERICA COLLAGEN MARKET, BY COUNTRY (VOLUME) 35
TABLE 22 NORTH AMERICA FACIAL LINE CORRECTION TREATMENT MARKET, BY COUNTRY (USD MILLION) 35
TABLE 23 NORTH AMERICA FACE-LIFT MARKET, BY COUNTRY (USD MILLION) 35
TABLE 24 NORTH AMERICA LIP TREATMENTS MARKET, BY COUNTRY (USD MILLION) 36
TABLE 25 NORTH AMERICA BOTULINUM TOXIN PRICE: BY COUNTRY: PRICE (USD) 36
TABLE 26 NORTH AMERICA HYALURONIC ACIDPRICE: BY COUNTRY (USD) 36
TABLE 27 NORTH AMERICA CALCIUM HYDROXYLAPATITE PRICE: BY COUNTRY (USD) 37
TABLE 28 NORTH AMERICA POLY-L-LACTIC ACID PRICE: BY COUNTRY (USD) 37
TABLE 29 NORTH AMERICA POLYMETHLMETHACRYLATE PRICE BY: COUNTRY (USD) 37
TABLE 30 NORTH AMERICA COLLAGEN PRICE: BY COUNTRY (USD) 37
TABLE 31 BOTULINUM TOXIN NUMBER OF FACIAL INJECTABLE PROCEDURES USING BOTULINUM TOXIN,
2020–2027 38
TABLE 32 NUMBER OF FACIAL INJECTABLE PROCEDURES USING HYALURONIC ACID 2020–2027 38
TABLE 33 NUMBER OF FACIAL INJECTABLE PROCEDURES USING CALCIUM HYDROXYLAPATITE 2020–2027 38
TABLE 34 NUMBER OF FACIAL INJECTABLE PROCEDURES USING POLY-L-LACTIC ACID 2020–2027 39
TABLE 35 NUMBER OF FACIAL INJECTABLE PROCEDURES USING POLYMETHYLMETHACRYLATE 2020–2027 39
TABLE 36 NUMBER OF FACIAL INJECTABLE PROCEDURES USING COLLAGEN (NON-SURGICAL FACE-LIFT PROCEDURES) (2020–2027) 39
TABLE 37 US FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 40
TABLE 38 US FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 41
TABLE 39 US FACIAL INJECTABLE MARKET, BY TYPE: PRICE (USD) 42
TABLE 40 CANADA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 42
TABLE 41 CANADA FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 43
TABLE 42 CANADA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 44
TABLE 43 CANADA FACIAL INJECTABLE MARKET, BY TYPE: PRICE (USD) 45
TABLE 44 EUROPE FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 45
TABLE 45 EUROPE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 47
TABLE 46 EUROPE FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 48
TABLE 47 EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 48
TABLE 48 RUSSIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 50
TABLE 49 GERMANY FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 51
TABLE 50 FRANCE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 51
TABLE 51 UK FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 52
TABLE 52 ITALY FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 52
TABLE 53 SPAIN FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 53
TABLE 54 REST OF EUROPE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 53
TABLE 55 EUROPE HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 54
TABLE 56 EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 54
TABLE 57 RUSSIA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 55
TABLE 58 GERMANY FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 55
TABLE 59 FRANCE FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 55
TABLE 60 UK FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 61 ITALY FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 62 SPAIN FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 63 REST OF EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 57
TABLE 64 ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 57
TABLE 65 ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 58
TABLE 66 ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 59
TABLE 67 ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 59
TABLE 68 ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY (USD MILLION) 60
TABLE 69 ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 61
TABLE 70 ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY USD MILLION 61
TABLE 71 ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 61
TABLE 72 ASIA-PACIFIC POLYMERS & PARTICLES MARKET, BY COUNTRY (USD MILLION) 62
TABLE 74 ASIA-PACIFIC POLY-L-LACTIC ACID MARKET, BY COUNTRY (VOLUME) 62
TABLE 75 ASIA-PACIFIC POLYMETHYLMETHACRYLATE MARKET, BY COUNTRY (VOLUME) 63
TABLE 76 ASIA-PACIFIC COLLAGEN MARKET, BY COUNTRY (USD MILLION) 63
TABLE 77 ASIA-PACIFIC FACIAL LINE CORRECTION TREATMENT MARKET, BY COUNTRY (USD MILLION) 63
TABLE 78 ASIA-PACIFIC FACE-LIFT MARKET, BY COUNTRY (USD MILLION) 64
TABLE 79 ASIA-PACIFIC LIP TREATMENTS MARKET, BY COUNTRY (USD MILLION) 64
TABLE 80 ASIA-PACIFIC BOTULINUM TOXIN PRICE: BY COUNTRY (USD) 65
TABLE 81 ASIA-PACIFIC HYALURONIC ACID PRICE: BY COUNTRY (USD) 65
TABLE 82 ASIA-PACIFIC CALCIUM HYDROXYLAPATITE PRICE: BY COUNTRY (USD) 65
TABLE 83 ASIA-PACIFIC POLY-L-LACTIC ACID PRICE: BY COUNTRY (USD) 66
TABLE 84 ASIA-PACIFIC POLYMETHYLMETHACRYLATE PRICE: BY COUNTRY (USD) 66
TABLE 85 NUMBER OF FACIAL INJECTABLE PROCEDURES USING BOTULINUM TOXIN 66
TABLE 86 NUMBER OF FACIAL INJECTABLE PROCEDURES USING HYALURONIC ACID 67
TABLE 87 NUMBER OF FACIAL INJECTABLE PROCEDURES USING CALCIUM HYDROXYLAPATITE 67
TABLE 88 NUMBER OF FACIAL INJECTABLE PROCEDURES USING POLY-L-LACTIC ACID 67
TABLE 89 NUMBER OF FACIAL INJECTABLE PROCEDURES USING POLYMETHYLMETHACRYLATE 68
TABLE 90 SOUTH KOREA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 68
TABLE 91 SOUTH KOREA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 68
TABLE 92 SOUTH KOREA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 69
TABLE 93 SOUTH KOREA FACIAL INJECTABLE BY TYPE: PRICE (USD) 69
TABLE 94 JAPAN FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 69
TABLE 95 JAPAN FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 70
TABLE 96 JAPAN FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 70
TABLE 97 JAPAN FACIAL INJECTABLE BY TYPE: PRICE (USD) 70
TABLE 98 CHINA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 71
TABLE 99 CHINA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 71
TABLE 100 CHINA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 71
TABLE 101 CHINA FACIAL INJECTABLE BY TYPE: PRICE (USD) 72
TABLE 102 INDIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 72
TABLE 103 INDIA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 72
TABLE 104 INDIA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 73
TABLE 105 INDIA FACIAL INJECTABLE BY TYPE: PRICE (USD) 73
TABLE 106 REST OF ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 73
TABLE 107 REST OF ASIA-PACIFIC FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 74
TABLE 108 GLOBAL FACIAL INJECTABLE SALES OF KEY MANUFACTURERS (2020 AND 2027) 75
TABLE 109 GLOBAL FACIAL INJECTABLE SALES BY MANUFACTURERS (2020 & 2027) 75
TABLE 110 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 76
TABLE 111 GALDERMA BASIC INFORMATION LIST 78
TABLE 112 ALLERGAN BASIC INFORMATION LIST 81
TABLE 113 MERZ BASIC INFORMATION LIST 85
TABLE 114 VALEANT PHARMACEUTICALS BASIC INFORMATION LIST 89
TABLE 115 INTEGRA LIFESCIENCES BASIC INFORMATION LIST 94
TABLE 116 SANOFI BASIC INFORMATION LIST 97
TABLE 117 SINCLAIR BASIC INFORMATION LIST 99
TABLE 118 SUNEVA MEDICAL BASIC INFORMATION LIST 101
TABLE 119 SCIVISION BASIC INFORMATION LIST 102
10 List Of Figures
FIGURE 1 PICTURE OF FACIAL INJECTABLE APPLICATION 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 PORTERS FIVE FORCES MODEL 22
FIGURE 4 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 29
FIGURE 5 NORTH AMERICA FACIAL INJECTABLE MARKET SHARE, BY TYPE, 2020 (%) 30
FIGURE 6 NORTH AMERICA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2020 (%) 32
FIGURE 7 US FACIAL INJECTABLE MARKET SHARE, BY TYPES, 2020 (%) 40
FIGURE 8 US FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2020 (%) 41
FIGURE 9 CANADA MARKET SHARE OF FACIAL INJECTABLE BY TYPES IN 2020 (%) 43
FIGURE 10 CANADA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2020 (%) 44
FIGURE 11 EUROPE FACIAL INJECTABLE MARKET SHARE, BY COUNTRY 2020, (%) 46
FIGURE 12 REVENUE OF FACIAL INJECTABLE BY REGIONS (2020–2027) 46
FIGURE 13 EUROPE FACIAL INJECTABLE REVENUE GROWTH RATE BY REGIONS (2020 & 2027) (%) 47
FIGURE 14 EUROPE FACIAL INJECTABLE MARKET SHARE, BY TYPE 2020 (%) 48
FIGURE 15 EUROPE FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2020 (%) 49
FIGURE 16 EUROPE FACIAL INJECTABLE SALES GROWTH RATE BY APPLICATION (2020–2027) 49
FIGURE 17 EUROPE FACIAL INJECTABLE MARKET, BY TYPE: PRICE (USD) 50
FIGURE 18 ASIA-PACIFIC FACIAL INJECTABLE MARKET SHARE, BY COUNTRY 2020 (%) 58
FIGURE 19 ASIA-PACIFIC FACIAL INJECTABLE MARKET SHARE, BY TYPE 2020 (%) 59
FIGURE 20 ASIA-PACIFIC FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2020 (%) 60
FIGURE 21 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 76
FIGURE 22 PRODUCT PICTURE 77
FIGURE 23 PRODUCT PICTURE 84
FIGURE 24 PRODUCT PICTURE 88
Market Segmentation
Facial Injectable Application Outlook (USD Billion, 2019-2030)
Facial Line Correction Treatment
Face Lift
Lip Treatments
Facial Injectable End User Outlook (USD Billion, 2019-2030)
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Facial Injectable Type Outlook (USD Billion, 2019-2030)
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Facial Injectable Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
North America Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
North America Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
US Outlook (USD Billion, 2019-2030)
US Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
US Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
US Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
CANADA Outlook (USD Billion, 2019-2030)
CANADA Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
CANADA Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
CANADA Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Europe Outlook (USD Billion, 2019-2030)
Europe Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Europe Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Europe Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Germany Outlook (USD Billion, 2019-2030)
Germany Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Germany Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Germany Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
France Outlook (USD Billion, 2019-2030)
France Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
France Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
France Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
UK Outlook (USD Billion, 2019-2030)
UK Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
UK Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
UK Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
ITALY Outlook (USD Billion, 2019-2030)
ITALY Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
ITALY Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
ITALY Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
SPAIN Outlook (USD Billion, 2019-2030)
Spain Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Spain Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Spain Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
REST OF EUROPE Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
REST OF EUROPE Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Asia-Pacific Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Asia-Pacific Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
China Outlook (USD Billion, 2019-2030)
China Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
China Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
China Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Japan Outlook (USD Billion, 2019-2030)
Japan Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Japan Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Japan Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
India Outlook (USD Billion, 2019-2030)
India Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
India Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
India Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Australia Outlook (USD Billion, 2019-2030)
Australia Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Australia Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Australia Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Rest of Asia-Pacific Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Rest of Asia-Pacific Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Rest of the World Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Rest of the World Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Middle East Outlook (USD Billion, 2019-2030)
Middle East Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Middle East Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Middle East Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Africa Outlook (USD Billion, 2019-2030)
Africa Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Africa Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Africa Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Latin America Outlook (USD Billion, 2019-2030)
Latin America Facial Injectable by Application
Facial Line Correction Treatment
Face Lift
Lip Treatments
Latin America Facial Injectable by End User
Hospitals
Specialty Clinics and Spa & Beauty Clinic
Latin America Facial Injectable by Type
Botulinum Toxin
Hyaluronic Acid
Polymers
Particles and Collagen
Research Methodology on Facial Injectable Market
Executive Summary
The purpose of this research methodology is to conduct a comprehensive study of the facial injectable market. This report aims to elucidate on the market’s current and future prospects. The study also aims to understand the factors driving market growth and assess the impact that these have on market dynamics. Additionally, it also seeks to provide industry-specific insights. To this end, a thorough market analysis is conducted to assess the impacting factors for facial injectable market growth. The research methodology employed to undertake this study is based on a systematic and phased approach.
Research Objectives
The primary goal of this research is to provide an exhaustive analysis of the global facial injectables market incorporating current trends, industry developments, product innovations and other influential factors. The report also provides insights into market trends and dynamics, key players, and emerging market segments.
Research Methodology
This research project employs qualitative and quantitative techniques. For the quantitative and primary data collection, a structured questionnaire is administered to the executives of major companies in the global facial injectables market. In addition, secondary research is also conducted and relevant trade publications, industry publications, and online databases are consulted to understand the trends in the market. Secondary data is used to gain an overview of the current market scenario. Furthermore, an analysis of the current market scenario and a SWOT analysis is done in order to gain a better understanding of the landscape and the conditions of the market.
Data Sources
In order to obtain comprehensive and accurate information about the global facial injectables market, several data sources such as trade associations and journals, industry magazines, and secondary statistical databases such as Hoovers, Financial Times, Datamonitor, Factiva, etc. are used. All the generated data are incorporated and analyzed to provide a comprehensive view of the global facial injectables market.
Assumptions
The report includes assumptions regarding the forecast period, market size, and market data. The report looks at the facial injectables market across all segments, including product types, applications, geographies, and end-users. The assumptions are made based on current market trends and historical data.
Data triangulation
To provide a robust analysis of the market, triangulation of the primary, secondary and analytical data is done. This method enables us to analyze the data in terms of market segmentation, trends, player shares and value chain.
Conclusion
The research methodology adopted for this report involves the review of existing information from various sources and the development of a comprehensive model for evaluating the facial injectables market. A thorough primary and secondary research is adopted for estimating the current and forecasted market size. Secondary data sources were used to obtain data on the global facial injectables market. We also conducted an in-depth analysis of the player landscape and identified market dynamics. Additionally, detailed interviews were conducted with key players and industry opinion leaders to gain an in-depth understanding of the market. This report presents an in-depth analysis of the facial injectables market and provides qualitative and quantitative insights into the market.